Report in English with a Dutch summary (KCE reports 45A)
Share Embed Flag
Download ePaper

Report in English with a Dutch summary (KCE reports 45A)

Report in English with a Dutch summary (KCE reports 45A) Report in English with a Dutch summary (KCE reports 45A)

kce.fgov.be
10.08.2013 Views

230 Screening for Colorectal Cancer KCE reports vol.45 234. Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst. 2005;97(13):989-97. 235. Robertson DJ, Greenberg ER, Beach M, Sandler RS, Ahnen D, Haile RW, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005;129(1):34-41. 236. Malila N, Anttila A, Hakama M. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. J Med Screen. 2005;12(1):28-32. 237. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982;49(4):819-25. 238. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982;23(10):835-42. 239. Clark JC, Collan Y, Eide TJ, Esteve J, Ewen S, Gibbs NM, et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. International Journal of Cancer. 1985;36(2):179-86. 240. Lee YS. Adenomas, metaplastic polyps and other lesions of the large bowel: an autopsy survey. Annals of the Academy of Medicine, Singapore. 1987;16(3):412-20. 241. Bombi JA. Polyps of the colon in Barcelona, Spain. An autopsy study. Cancer. 1988;61(7):1472-6. 242. Lee YS. Early malignant lesions of the colorectum at autopsy. Diseases of the Colon & Rectum. 1988;31(4):291-7. 243. Szczepanski W, Urban A, Wierzchowski W. Colorectal polyps in autopsy material. Part I. Adenomatous polyps. Patologia Polska. 1992;43(3):79-85. 244. Rex DK. Current colorectal cancer screening strategies: overview and obstacles to implementation. Rev Gastroenterol Disord. 2002;2 Suppl 1(1):S2-11. 245. Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin. 2003;53(1):44-55. 246. Walsh JM, Terdiman JP. Colorectal cancer screening: scientific review. JAMA. 2003;289(10):1288-96. 247. Deenadayalu VP, Rex DK. Fecal-based DNA assays: a new, noninvasive approach to colorectal cancer screening. Cleve Clin J Med. 2004;71(6):497-503. 248. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, Colorectal Cancer Study G. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;351(26):2704-14. 249. Kahi CJ, Rex DK. Current and future trends in colorectal cancer screening. Cancer Metastasis Rev. 2004;23(1-2):137-44. 250. Kanaoka S, Yoshida K, Miura N, Sugimura H, Kajimura M. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening. Gastroenterology. 2004;127(2):422-7. 251. Mak T, Lalloo F, Evans DG, Hill J. Molecular stool screening for colorectal cancer. The British journal of surgery. 2004;91(7):790-800. 252. Tagore KS, Levin TR, Lawson MJ. The evolution to stool DNA testing for colorectal cancer. Aliment Pharmacol Ther. 2004;19(12):1225-33. 253. Agrawal J, Syngal S. Colon cancer screening strategies. Curr Opin Gastroenterol. 2005;21(1):59-63. 254. Bromer MQ, Weinberg DS. Screening for colorectal cancer--now and the near future. Semin Oncol. 2005;32(1):3-10. 255. Davies RJ, Miller R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer. 2005;5(3):199-209. 256. Ferretti G, Bria E, Carlini P, Felici A, Giannarelli D, Cuppone F, et al. Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening? Gut. 2005;54(6):891.

KCE reports vol.45 Screening for Colorectal Cancer 231 257. Greenwald B. The stool DNA test: an emerging technology in colorectal cancer screening. Gastroenterol Nurs. 2005;28(1):28-32. 258. Hardison DM, Shuber AP. Stool DNA: a viable option for colorectal cancer screening. Gastroenterology. 2005;129(6):2128-9; author reply 9. 259. Kronborg O. Future perspectives in screening for colorectal cancer. Ugeskrift for laeger. 2005;167(44):4193-4. 260. Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Goke B, et al. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clinical Gastroenterology & Hepatology. 2005;3(2):142-9. 261. Lidofsky S. Detection and prevention of colon cancer: colonoscopy, virtual colonoscopy, and DNA stool tests. Med Health R I. 2005;88(3):82-5. 262. Moshkowitz M, Arber N. Emerging technologies in colorectal cancer screening. Surg Oncol Clin N Am. 2005;14(4):723-46. 263. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: Molecular approaches. Gastroenterology. 2005;128(1):192-206. 264. Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE. Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol. 2005;100(6):1393-403. 265. Hawk ET, Levin B. Colorectal cancer prevention. Journal of Clinical Oncology. 2005;23(2):378-91. 266. St John DJ. Screening for rectal cancer. Hepatogastroenterology. 2000;47(32):305-9. 267. Young GP, St John DJ, Winawer SJ, Rozen P, Who, Omed. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002;97(10):2499-507. 268. National Health Committee Working Party on Population Screening for Colorectal Cancer. Recommendations on population screening for colorectal cancer in New Zealand. New Zealand Medical Journal. 1999;112(1080):4-6. 269. Van Deen I. Use of tinctura Guaiaci as carrier of ozone in very small quantities of blood, especially in medico-forensic diagnosis. Ned Tijdschr Geneeskd. 1957;101(1):47-9. 270. Blue Cross - Blue Shield Association. Immunochemical versus guaiac fecal occult blood tests. Technology Evaluation Center (TEC). 2004:26. 271. Berchi C, et al. Cost-Effectiveness Analysis of Two Strategies for Mass Screening for Colorectal Cancer in France. Health Economics. 2004;13(3):227-38. 272. Wong WM, Lam SK, Cheung KL, Tong TS, Rozen P, Young GP, et al. Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer. 2003;97(10):2420-4. 273. Rozen P, Waked A, Vilkin A, Levi Z, Niv Y. Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood. Medical Science Monitor. 2006;12(6). 274. Janssens JF. Faecal occult blood test as a screening test for colorectal cancer. Acta Gastroenterol Belg. 2005;68(2):244-6. 275. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(2):132-41. 276. Ho C, Jacobs P, Sandha G, Noorani HZ, Skidmore B. Non-physicians performing screening flexible sigmoidoscopy: clinical efficacy and cost-effectiveness. Canadian Coordinating Office for Health Technology Assessment (CCOHTA). 2006:41. 277. Schoenfeld P, Lipscomb S, Crook J, Dominguez J, Butler J, Holmes L, et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology. 1999;117(2):312-8.

<strong>KCE</strong> <strong>reports</strong> vol.45 Screen<strong>in</strong>g for Colorectal Cancer 231<br />

257. Greenwald B. The stool DNA test: an emerg<strong>in</strong>g technology <strong>in</strong> colorectal cancer<br />

screen<strong>in</strong>g. Gastroenterol Nurs. 2005;28(1):28-32.<br />

258. Hardison DM, Shuber AP. Stool DNA: a viable option for colorectal cancer<br />

screen<strong>in</strong>g. Gastroenterology. 2005;129(6):2128-9; author reply 9.<br />

259. Kronborg O. Future perspectives <strong>in</strong> screen<strong>in</strong>g for colorectal cancer. Ugeskrift for<br />

laeger. 2005;167(44):4193-4.<br />

260. Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Goke B, et al. Analysis of<br />

promoter methylation <strong>in</strong> stool: a novel method for the detection of colorectal<br />

cancer. Cl<strong>in</strong>ical Gastroenterology & Hepatology. 2005;3(2):142-9.<br />

261. Lidofsky S. Detection and prevention of colon cancer: colonoscopy, virtual<br />

colonoscopy, and DNA stool tests. Med Health R I. 2005;88(3):82-5.<br />

262. Moshkowitz M, Arber N. Emerg<strong>in</strong>g technologies <strong>in</strong> colorectal cancer screen<strong>in</strong>g. Surg<br />

Oncol Cl<strong>in</strong> N Am. 2005;14(4):723-46.<br />

263. Osborn NK, Ahlquist DA. Stool screen<strong>in</strong>g for colorectal cancer: Molecular<br />

approaches. Gastroenterology. 2005;128(1):192-206.<br />

264. Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE. Non<strong>in</strong>vasive test<strong>in</strong>g for colorectal<br />

cancer: a review. Am J Gastroenterol. 2005;100(6):1393-403.<br />

265. Hawk ET, Lev<strong>in</strong> B. Colorectal cancer prevention. Journal of Cl<strong>in</strong>ical Oncology.<br />

2005;23(2):378-91.<br />

266. St John DJ. Screen<strong>in</strong>g for rectal cancer. Hepatogastroenterology. 2000;47(32):305-9.<br />

267. Young GP, St John DJ, W<strong>in</strong>awer SJ, Rozen P, Who, Omed. Choice of fecal occult<br />

blood tests for colorectal cancer screen<strong>in</strong>g: recommendations based on<br />

performance characteristics <strong>in</strong> population studies: a WHO (World Health<br />

Organization) and OMED (World Organization for Digestive Endoscopy) report.<br />

Am J Gastroenterol. 2002;97(10):2499-507.<br />

268. National Health Committee Work<strong>in</strong>g Party on Population Screen<strong>in</strong>g for Colorectal<br />

Cancer. Recommendations on population screen<strong>in</strong>g for colorectal cancer <strong>in</strong> New<br />

Zealand. New Zealand Medical Journal. 1999;112(1080):4-6.<br />

269. Van Deen I. Use of t<strong>in</strong>ctura Guaiaci as carrier of ozone <strong>in</strong> very small quantities of<br />

blood, especially <strong>in</strong> medico-forensic diagnosis. Ned Tijdschr Geneeskd.<br />

1957;101(1):47-9.<br />

270. Blue Cross - Blue Shield Association. Immunochemical versus guaiac fecal occult<br />

blood tests. Technology Evaluation Center (TEC). 2004:26.<br />

271. Berchi C, et al. Cost-Effectiveness Analysis of Two Strategies for Mass Screen<strong>in</strong>g for<br />

Colorectal Cancer <strong>in</strong> France. Health Economics. 2004;13(3):227-38.<br />

272. Wong WM, Lam SK, Cheung KL, Tong TS, Rozen P, Young GP, et al. Evaluation of<br />

an automated immunochemical fecal occult blood test for colorectal neoplasia<br />

detection <strong>in</strong> a Ch<strong>in</strong>ese population. Cancer. 2003;97(10):2420-4.<br />

273. Rozen P, Waked A, Vilk<strong>in</strong> A, Levi Z, Niv Y. Evaluation of a desk top <strong>in</strong>strument for<br />

the automated development and immunochemical quantification of fecal occult<br />

blood. Medical Science Monitor. 2006;12(6).<br />

274. Janssens JF. Faecal occult blood test as a screen<strong>in</strong>g test for colorectal cancer. Acta<br />

Gastroenterol Belg. 2005;68(2):244-6.<br />

275. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screen<strong>in</strong>g for colorectal cancer<br />

<strong>in</strong> adults at average risk: a <strong>summary</strong> of the evidence for the U.S. Preventive Services<br />

Task Force. Ann Intern Med. 2002;137(2):132-41.<br />

276. Ho C, Jacobs P, Sandha G, Noorani HZ, Skidmore B. Non-physicians perform<strong>in</strong>g<br />

screen<strong>in</strong>g flexible sigmoidoscopy: cl<strong>in</strong>ical efficacy and cost-effectiveness. Canadian<br />

Coord<strong>in</strong>at<strong>in</strong>g Office for Health Technology Assessment (CCOHTA). 2006:41.<br />

277. Schoenfeld P, Lipscomb S, Crook J, Dom<strong>in</strong>guez J, Butler J, Holmes L, et al. Accuracy<br />

of polyp detection by gastroenterologists and nurse endoscopists dur<strong>in</strong>g flexible<br />

sigmoidoscopy: a randomized trial. Gastroenterology. 1999;117(2):312-8.

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!